A.R.T. Advisors’s Neos Therapeutics, Inc NEOS Stock Holding History

A.R.T. Advisors’s Portfolio NEOS Stock Details NEOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-23,524	Closed	-$35K	–	1881
2019 Q3	$35K	Buy	+23,524	New	+$38.1K	﹤0.01%	1343
2018 Q4	–	Sell	-21,670	Closed	-$105K	–	1810
2018 Q3	$105K	Sell	21,670 -2,711	-11%	-$15.4K	﹤0.01%	1270
2018 Q2	$152K	Buy	+24,381	New	+$182K	0.01%	1268

Other funds holding NEOS

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

A.R.T. Advisors's NEOS Position: Q4 2019 in Review

A.R.T. Advisors sold out of Neos Therapeutics, Inc (NEOS) in Q4 2019, closing a stake of 23,524 shares — an estimated $35K sold.

A.R.T. Advisors first reported a position in NEOS in Q2 2018 and held it in 3 quarters. The position peaked at $152K in Q2 2018. 54 funds tracked by Wall St. Rank hold NEOS as of Q4 2019.

A.R.T. Advisors reported no remaining Neos Therapeutics, Inc position as of Q4 2019 after selling out during the quarter.
A.R.T. Advisors sold 23,524 Neos Therapeutics, Inc shares in Q4 2019, an estimated $35K.
A.R.T. Advisors first reported a position in Neos Therapeutics, Inc in Q2 2018 and held it in 3 quarters.
A.R.T. Advisors's Neos Therapeutics, Inc position peaked at $152K in Q2 2018.
54 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q4 2019.

Based on A.R.T. Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.